Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Status:
Recruiting
Trial end date:
2027-11-01
Target enrollment:
Participant gender:
Summary
Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in
subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.